Cefobac

Cefobac125 mg/5 ml

Powder for Suspension

Cefuroxime Axetil

Popular Pharmaceuticals Ltd.

Product Code : 3102
MRP 198.75
10% Off
Best PriceTk
/
1
Section

Alternatives

See All
Product Image
10% Off

Cerox-A125 mg/5 m

Cefuroxime Axetil

ACI Limited

179.42
199.35
Add to cart
Product Image
10% Off

Famicef125 mg/5 m

Cefuroxime Axetil

ACME Laboratories Ltd.

179.41
199.34
Add to cart
Product Image
10% Off

Kilbac125 mg/5 m

Cefuroxime Axetil

Incepta Pharmaceuticals Ltd.

178.20
198.00
Add to cart
Product Image
8% Off

Rofurox125 mg/5 m

Cefuroxime Axetil

Radiant Pharmaceuticals Ltd.

299.00
325.00
Add to cart
Product Image
10% Off

Sefur125 mg/5 m

Cefuroxime Axetil

Opsonin Pharma Ltd.

178.87
198.75
Add to cart
Product Image
10% Off

Staxim125 mg/5 m

Cefuroxime Axetil

Delta Pharma Ltd.

153.00
170.00
Add to cart
Product Image
10% Off

Axet125 mg/5 m

Cefuroxime Axetil

Orion Pharma Ltd.

194.81
216.45
Add to cart
Product Image
10% Off

Axicef125 mg/5 m

Cefuroxime Axetil

Unimed Unihealth MFG. Ltd.

180.00
200.00
Add to cart
Product Image
10% Off

Axim125 mg/5 m

Cefuroxime Axetil

Aristopharma Ltd.

202.50
225.00
Add to cart
Product Image
10% Off

Fixcef125 mg/5 m

Cefuroxime Axetil

Navana Pharmaceuticals Ltd.

178.75
198.61
Add to cart
Product Image
10% Off

Furex125 mg/5 m

Cefuroxime Axetil

Drug International Ltd.

203.13
225.70
Add to cart
Product Image
10% Off

Furoget125 mg/5 m

Cefuroxime Axetil

Get Well Ltd.

175.50
195.00
Add to cart
Product Image
10% Off

Fuxtil125 mg/5 m

Cefuroxime Axetil

Pharmasia Limited

178.20
198.00
Out Of Stock
Product Image
10% Off

Kilmax125 mg/5 m

Cefuroxime Axetil

Eskayef Bangladesh Ltd.

178.20
198.00
Add to cart
Product Image
10% Off

Merocef125 mg/5 m

Cefuroxime Axetil

Ibn-Sina Pharmaceuticals Ltd.

180.00
200.00
Add to cart
Product Image
10% Off

Mextil125 mg/5 m

Cefuroxime Axetil

Biopharma Laboratories Ltd.

181.21
201.35
Add to cart
Product Image
10% Off

Roxilab125 mg/5 m

Cefuroxime Axetil

Labaid Pharma Ltd.

243.73
270.81
Add to cart
Product Image
10% Off

Secomax125 mg/5 m

Cefuroxime Axetil

General Pharmaceuticals Ltd.

181.21
201.35
Add to cart
Product Image
8% Off

Sefurox125 mg/5 m

Cefuroxime Axetil

Synovia Pharma PLC

183.39
199.34
Add to cart
Product Image
10% Off

Segorin125 mg/5 m

Cefuroxime Axetil

Pacific Pharmaceuticals Ltd.

180.00
200.00
Add to cart
Product Image
10% Off

Turbocef125 mg/5 m

Cefuroxime Axetil

Beximco Pharmaceuticals Ltd.

216.00
240.00
Add to cart
Product Image
10% Off

Winfax125 mg/5 m

Cefuroxime Axetil

The White Horse Pharma

178.20
198.00
Out Of Stock
Product Image
10% Off

Xefrim125 mg/5 m

Cefuroxime Axetil

Beacon Pharmaceuticals Ltd.

179.42
199.35
Add to cart
Product Image
10% Off

Ximetil125 mg/5 m

Cefuroxime Axetil

Globe Pharmaceuticals Ltd.

178.20
198.00
Add to cart
Product Image
10% Off

Xitil125 mg/5 m

Cefuroxime Axetil

Ziska Pharmaceuticals Ltd.

178.20
198.00
Add to cart
Product Image
7% Off

Xorimax125 mg/5 m

Cefuroxime Axetil

SANDOZ (A Novartis Division)

233.44
251.01
Add to cart
Section

Medicine overview

Indications of Cefobac 125 mg/5 ml

It is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. ... Read moreIt is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains) Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains). Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes. Urinary tract infections caused by E.coli or Klebsiella pneumoniae. Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains). Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae. Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.

Theropeutic Class

Second generation Cephalosporins

Pharmacology

Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.

Dosage of Cefobac 125 mg/5 ml

Tablet or Suspension- Adolescents and adults (13 years and older)- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days Uncomplicated Gonorrhoea: 1000 mg Single dose Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days Early Lyme disease: 500 mg b.i.d. for 20 days Paediatric Patients (3 months to 12 years)- Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days Acute otitis media: 30 mg/kg/day b.i.d for 10 days Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days Impetigo: 30 mg/kg/day b.i.d for 10 days Parenteral- Adult: 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms. Children (above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections. Neonate: 30 - 100 mg/kg/day given in 2 or 3 equally divided doses. Surgical prophylaxis: 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures. Pneumonia: 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days. Acute exacerbations of chronic bronchitis: 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.) In Gonorrhoea: Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock). In Meningitis: Adult: 3 gm IV injection three times daily. Children (above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement. Neonate: 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated. In bone and joint infections: Adult: 1.5 gm IV injection four times daily. Children (above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.

Administration of Cefobac 125 mg/5 ml

The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5o C

Interaction of Cefobac 125 mg/5 ml

No potentially hazardous interactions have been reported.

Contraindications

Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.

Side Effects of Cefobac 125 mg/5 ml

Adverse effects to Cefuroxime have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.

Pregnancy & Lactation

US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.

Precautions & Warnings

Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefuroxime has shown, that is not likely to be a problem at the recommended to dose levels.

Storage Conditions

Store in a cool, dry place (below 30o C), away from light & moisture. Keep out of the reach of children.

Reconstitution

For 750 mg intramuscular injection: Add 3 ml water for injection to vial and then shake gently for dispersion.For 750 mg intravenous injection: Add 8 ml water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.For 1.5 g intravenous injection: Add 16 ml Water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.

Drug Classes

Second generation Cephalosporins

Mode Of Action

Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.

Pregnancy

US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.